A carregar...
Combination Therapy: Histone Deacetylase Inhibitors and Platinum-based Chemotherapeutics for Cancer
One of the most promising strategies to increase the efficacy of standard chemotherapy drugs is by combining them with low doses of histone deacetylases inhibitors (HDACis). Regarded as chemosensitizers, the addition of well-tolerated doses of HDACis to platinum-based chemotherapeutics has been prov...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3546543/ https://ncbi.nlm.nih.gov/pubmed/23032720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2012.09.018 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|